Toshiyasu Ishimaru

Title: Toshiyasu Ishimaru: Innovator in Cephem Compounds

Introduction

Toshiyasu Ishimaru is a notable inventor based in Suita, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of cephem compounds derived from cephalosporin C. His work has implications for the synthesis of bacteriocidally active derivatives, which are crucial in the medical field.

Latest Patents

Ishimaru holds a patent for a compound described as 7-[5-N-(n-Butoxyethoxy carbonyl and 2-chloroethoxy carbonyl)-amino]. This invention provides valuable cephem compounds that serve as intermediates for synthesizing other active cephem derivatives. The compounds are designed to be easily extractable from aqueous solutions using organic solvents, thereby improving the yield of cephalosporin C from fermentation broth filtrates. The process involves reacting cephalosporin C with a substituted chloroformate compound, leading to the formation of cephem compounds that can further be converted into 7-acylamidocephalosporanic acid or 7-aminocephalosporanic acid through successive reactions.

Career Highlights

Ishimaru is associated with Meiji Seika Kaisha, Ltd., a company known for its advancements in pharmaceutical research and development. His work has contributed to the company's reputation for innovation in the field of antibiotics and other medicinal compounds.

Collaborations

Ishimaru has collaborated with Shigeo Seki, a fellow researcher, to further explore the potential of cephem compounds and their applications in medicine.

Conclusion

Toshiyasu Ishimaru's contributions to the field of cephem compounds highlight his innovative spirit and dedication to advancing pharmaceutical science. His work continues to influence the development of effective medical treatments.